Table 2 Angiographic, procedural, post-procedural follow-up data for each patient
Case no. | Type and site | Angiographic findings | Endosession | Embolic material/tools | Rebleeding within 30 days | Rebleeding after 30 days | Mortality (Y/N) (survival days) | ||
|---|---|---|---|---|---|---|---|---|---|
Blush | Neovascularity | Extravasation | |||||||
1 | Gastric AC | Y | Y | Y | 1 | PVA | N | N | Y/44 |
2 | Gastric AC | Y | N | N | 2 | Gel sponge then PVA | Y | N | Y/68 |
3 | Gastric AC | N | Y | N | 1 | PVA | N | N | N |
4 | Gastric AC | Y | N | N | 1 | Gel sponge | N | N | N |
5 | Gastric AC | Y | Y | N | 1 | PVA | N | N | N |
6 | Gastric AC | Y | N | N | 1 | PVA | N | N | N |
7 | Gastric AC | Y | Y | Y | 1 | PVA | N | N | Y/112 |
8 | Gastric AC | Y | Y | N | 1 | PVA | Y | N | N |
9 | Gastric lymphoma | N | N | N | 2 | Gel sponge then PVA | N | Y | N |
10 | Gastric lymphoma | Y | Y | N | 1 | PVA | N | N | N |
11 | Gastric lymphoma | Y | N | N | 2 | Gel sponge then PVA | N | Y | N |
12 | SI GIST | Y | Y | N | 1 | PVA | N | N | Y/29 |
13 | SI GIST | Y | Y | N | 1 | PVA | N | N | N |
14 | Colonic AC infiltrating Du | Y | Y | N | 1 | Gel sponge | Y | N | Y/98 |